Bloodstream infection after kidney transplantation: Epidemiology, microbiology, associated risk factors, and outcome

Transplantation

Volumn 90, Issue 5, 2010, Pages 581-587

  Silva Jr , Moacyr ^a   Marra, Alexandre R ^a   Pereira, Carlos A P ^a   Medina Pestana, José O ^a   Camargo, Luis F A ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

BSI; Kidney transplant; Mortality; Risk factors

Indexed keywords

AZATHIOPRINE; CEFALOTIN; COTRIMOXAZOLE; CYCLOSPORIN; INTERLEUKIN 2 RECEPTOR ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; BLOODSTREAM INFECTION; FEMALE; HUMAN; INFECTION PREVENTION; INFECTION RISK; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LUNG INSUFFICIENCY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MICROBIOLOGICAL PARAMETERS; ORGAN DONOR; PRIORITY JOURNAL; SCORING SYSTEM; SHOCK; TREATMENT OUTCOME; ADOLESCENT; BACTEREMIA; BLOOD; CADAVER; DONOR; LIVING DONOR; MICROBIOLOGY; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDY; RISK FACTOR; SURGERY; URETER; URINARY TRACT INFECTIONS;

ADOLESCENT; ADULT; BACTEREMIA; CADAVER; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; TISSUE DONORS; TREATMENT OUTCOME; URETER; URINARY TRACT INFECTIONS;

EID: 77957285909     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181e8a680     Document Type: Article

References (27)

1. Abbott KC, Oliver JD, Hypolite I, et al. Hospitalizations for bacterial septicemia after renal transplantation in the United States. Am J Neph-rol 2001; 21: 120.
2. Alangaden GJ, Thyagarajan R, Gruber SA, et al. Infectious complications after kidney transplantation: Current epidemiology and associated risk factors. Clin Transplant 2006; 20: 401.
3. Candel FJ, Grima E, Matesanz M, et al. Bacteremia and septic shock after solid-organ transplantation. Transplant Proc 2005; 37: 4097
4. HarbarthS,FerrièreK,HugonnetS,et al. Epidemiology and prognostic determinants of bloodstream infections in surgical intensive care. Arch Surg 2002; 137: 1353.
5. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357: 2601.
6. Palmer SM, Alexander BD, Sanders LL, et al. Significance of blood stream infection after lung transplantation: Analysisin 176 consecutive patients. Transplant 2000; 69: 2360.
7. Foley JM, Paunio M, Lyytikäinen O, et al. Bacteremia among kidney transplant recipients: A case-control study of risk factors and short-term outcomes. Scand J Infect Dis 2000; 32: 69.
8. McClean K, Ktneteman N, Taylor G. Comparative risk of bloodstream infection in organ transplant recipients. Infect Control Hosp Epidemiol 1994; 15: 582.
9. Charlson ME, Sax FL, Mackenzie CR, et al. Assesing illness severity: Does clinical judgment work? J Chronic Dis 1986; 39: 439.
10. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 818.
11. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 2006; M2-A9. Wayne, PA.
12. Garner JS, Jarvis WR, Emori TC, et al. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16: 128.
13. Husain S, Chan KM, Palmer SM, et al. Bacteremia in lung transplant recipients in the current era. Am J Transplant 2006; 6: 3000.
14. Kollef MH, Micek ST. Strategies to prevent antimicrobial resistance in the intensive care unit. Crit Care Med 2005; 33: 1845.
15. Silveira FP, Marcos A, Kwak EJ, et al. Bloodstream infections in organ transplant recipients receiving alemtuzumab: No evidence of occurrence of organisms typically associated with profound T cell depletion. J Infect 2006; 53: 241.
16. Dantas SRPE, Kuboyama RH, Mazzali M, et al. Nosocomial infections in renal transplant patients: Risk factors and treatment implications associated with urinary tract and surgical site infections. J Hosp Infect 2006; 63: 117.
17. Clesca P, Dirlando M, Park SI, et al. Thymoglobulin and rate of infectious complications after transplantation. Transplant Proc 2007; 39: 463.
18. Singh N, Wagner MM, Obman A, et al. Bacteremias in liver transplant recipients: Shift toward gram-negative bacteria as predominant pathogens. Liver Transplant 2004; 10: 844.
19. Biz E, Pereira CAP, Moura LAR, et al. The use of cyclosporine modifies the clinical and histoplathological presentation of tuberculosis after renal transplantation. Rev Inst Med Trop S Paulo 2000; 42: 225.
20. Brayman KL, Stephanian E, Matas AJ, et al. Analysis of infectious complications occurring after solid-organ transplantation. Arch Surg 1992; 127: 38.
21. Gill JS, Abichandani R, Kausz AT, et al. Mortality after kidney transplant failure: The impact of non-immunologic factors. Kidney Int 2002; 62: 1875.
22. Sansalone CV, Maione G, Aseni P, et al. Advantages of short time ureteric stening for prevention of urological complications in kidney transplantation: An 18-year experience. Transplant Proc 2005; 37: 2511.
23. Rabkin DG, Stifelman MD, Birkhoff J, et al. Early catheter removal decreases incidenceof urinary tract infectionsin renal transplant recipients. Transplant Proc 1998; 30: 4314.
24. Osman Y, Ali-El-Dein B, Shokeir AA, et al. Routine insertion of ureteral stent in live-donor renal transplantation: Is it worthwhile. Urol 2005; 65: 867.
25. Lumbreras C, Sanz F, González A, et al. Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients. Clin Infect Dis 2001; 33: 722.
26. Moreno A, Cervera C, Gavaldá J, et al. Bloodstream infections among transplant recipients: Results of a nationwide surveillance in Spain. Am J Transplant 2007; 7: 2579.
27. Diekema DJ, Beekmann SE, Chapin KC, et al. Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J Clin Microbiol 2003; 41: 3655.